Related Experiment Video
Updated: May 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Systemic sclerosis and the heart
John L Parks1, Marian H Taylor, Laura P Parks
1Division of Cardiology, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA.
Insights
Systemic sclerosis (SSc) frequently causes heart disease, impacting the pericardium, myocardium, and conduction system. Early recognition of scleroderma heart disease is crucial for effective patient management, despite the lack of specific therapies.
Area of Science:
- Cardiology
- Rheumatology
- Internal Medicine
Background:
- Heart disease is a common complication in systemic sclerosis (SSc), affecting both diffuse and limited cutaneous forms.
- Increased awareness of scleroderma heart disease stems from advancements in sensitive diagnostic modalities.
- Cardiac involvement in SSc often manifests in the pericardium, myocardium, and cardiac conduction system.
Purpose of the Study:
- To highlight the prevalence and multifaceted nature of cardiac complications in systemic sclerosis.
- To emphasize the need for multidisciplinary collaboration in managing scleroderma heart disease.
- To underscore the importance of early detection for improved patient outcomes.
Main Methods:
- Review of current literature and clinical awareness regarding cardiac involvement in SSc.
- Analysis of how sensitive diagnostic tools have increased the recognition of scleroderma heart disease.
- Discussion of the typical patterns of cardiac affection in SSc patients.
Main Results:
- Scleroderma heart disease is a frequent, often silent, complication of systemic sclerosis.
- Cardiac involvement encompasses the pericardium, myocardium, and conduction system.
- Early identification of the specific type of heart disease is key.
Conclusions:
- While no specific treatment exists for scleroderma heart disease, early diagnosis is vital.
- Multidisciplinary management involving internists, cardiologists, and rheumatologists is essential.
- Prompt recognition and management can lead to more effective care for patients with SSc.
Abstract:
Heart disease, either clinically apparent or silent, is a frequent complication of systemic sclerosis (SSc, scleroderma) and may affect both patients with diffuse cutaneous and limited cutaneous SSc. The availability of more sensitive modalities has led to an increased awareness of scleroderma heart disease, which often involves the pericardium, myocardium, and cardiac conduction system. This awareness of cardiac involvement requires attention and interventions led by internists, cardiologists, and rheumatologists. Although no specific therapy exists for scleroderma heart disease, early recognition of the presence and type of scleroderma heart disease may lead to more effective management of patients with scleroderma.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy

